| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.005 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |